questionsmedicales.fr
Cellules
Thymocytes
Thymocytes : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Thymocytes
Biopsie
Tests sanguins
Imagerie par résonance magnétique
Cytologie
Thymocytes
Tests génétiques
Thymocytes
Anomalies génétiques
Fonction immunitaire
Thymocytes
Tests fonctionnels
Marqueurs cellulaires
Thymocytes
CD4
Symptômes
5
Immunodéficience
Infections
Thymocytes
Troubles auto-immuns
Lymphomes
Thymocytes
Réponse immunitaire
Thymocytes
Santé globale
Maladies immunitaires
Thymocytes
Infections récurrentes
Prévention
5
Prévention
Vaccinations
Thymocytes
Hygiène
Prévention
Thymocytes
Dépistage
Immunodéficience
Thymocytes
Nutrition
Thymocytes
Fonction immunitaire
Stress
Thymocytes
Immunité
Traitements
5
Immunosuppresseurs
Thérapie génique
Thymocytes
Transplantation
Thymus
Déficits immunitaires
Thymocytes
Traitements ciblés
Fonction immunitaire
Thérapies biologiques
Thymocytes
Réponse immunitaire
Médecine personnalisée
Thymocytes
Traitements
Complications
5
Infections
Lymphomes
Thymocytes
Troubles auto-immuns
Thymocytes
Maladies
Complications
Thymocytes
Traitements
Qualité de vie
Infections
Thymocytes
Fréquence
Complications
Thymocytes
Facteurs de risque
5
Facteurs de risque
Infections virales
Thymocytes
Maladies génétiques
Thymocytes
Risque
Mode de vie
Thymocytes
Risque
Expositions environnementales
Thymocytes
Risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thymocytes : Questions médicales les plus fréquentes",
"headline": "Thymocytes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thymocytes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-03",
"dateModified": "2025-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thymocytes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cellules",
"url": "https://questionsmedicales.fr/mesh/D002477",
"about": {
"@type": "MedicalCondition",
"name": "Cellules",
"code": {
"@type": "MedicalCode",
"code": "D002477",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Thymocytes",
"alternateName": "Thymocytes",
"code": {
"@type": "MedicalCode",
"code": "D060168",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Lie Wang",
"url": "https://questionsmedicales.fr/author/Lie%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China."
}
},
{
"@type": "Person",
"name": "Ravshan Z Sabirov",
"url": "https://questionsmedicales.fr/author/Ravshan%20Z%20Sabirov",
"affiliation": {
"@type": "Organization",
"name": "Institute of Biophysics and Biochemistry, National University of Uzbekistan, Tashkent, Uzbekistan."
}
},
{
"@type": "Person",
"name": "Chao Chen",
"url": "https://questionsmedicales.fr/author/Chao%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Special Key Laboratory of Gene Detection and Therapy of the Guizhou Province, Zunyi Medical University, Zunyi, China."
}
},
{
"@type": "Person",
"name": "Lin Xu",
"url": "https://questionsmedicales.fr/author/Lin%20Xu",
"affiliation": {
"@type": "Organization",
"name": "Special Key Laboratory of Gene Detection and Therapy of the Guizhou Province, Zunyi Medical University, Zunyi, China, xulinzhouya@163.com."
}
},
{
"@type": "Person",
"name": "Pilar López-Nieva",
"url": "https://questionsmedicales.fr/author/Pilar%20L%C3%B3pez-Nieva",
"affiliation": {
"@type": "Organization",
"name": "Genome Dynamics and Function Program, Genome Decoding Department, Severo Ochoa Molecular Biology Center (CBMSO), CSIC-Madrid Autonomous University, 28049 Madrid, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "[Tic douloureux sustained by an eye tumor].",
"datePublished": "2023-04-27",
"url": "https://questionsmedicales.fr/article/37179479",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Adnexal neoplasms of the eye.",
"datePublished": "2024-01-26",
"url": "https://questionsmedicales.fr/article/38281687",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clindermatol.2024.01.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "OVOL1 immunohistochemical expression is a useful tool to diagnose invasion in ocular surface squamous neoplasms.",
"datePublished": "2022-07-01",
"url": "https://questionsmedicales.fr/article/35787378",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.oftale.2022.06.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Lymphoma of the eye and its adnexa : Modern pathological diagnostics and systemic treatment].",
"datePublished": "2022-05-23",
"url": "https://questionsmedicales.fr/article/35925409",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00347-022-01650-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Radio-luminescent imaging for rapid, high-resolution eye plaque loading verification.",
"datePublished": "2022-10-17",
"url": "https://questionsmedicales.fr/article/36183146",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/mp.16003"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Thymocytes",
"item": "https://questionsmedicales.fr/mesh/D060168"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thymocytes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thymocytes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thymocytes",
"description": "Comment diagnostiquer une anomalie des thymocytes ?\nQuels examens sont utilisés pour évaluer les thymocytes ?\nLes tests génétiques sont-ils utiles pour les thymocytes ?\nPeut-on évaluer la fonction des thymocytes ?\nQuels marqueurs sont utilisés pour identifier les thymocytes ?",
"url": "https://questionsmedicales.fr/mesh/D060168?mesh_terms=Eye+Neoplasms#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thymocytes",
"description": "Quels symptômes indiquent un problème avec les thymocytes ?\nLes anomalies des thymocytes causent-elles des symptômes spécifiques ?\nComment les thymocytes affectent-ils la santé globale ?\nLes symptômes d'une maladie des thymocytes sont-ils visibles ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D060168?mesh_terms=Eye+Neoplasms#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thymocytes",
"description": "Comment prévenir les maladies liées aux thymocytes ?\nY a-t-il des mesures préventives spécifiques ?\nLes dépistages réguliers sont-ils recommandés ?\nL'alimentation influence-t-elle la santé des thymocytes ?\nLe stress a-t-il un impact sur les thymocytes ?",
"url": "https://questionsmedicales.fr/mesh/D060168?mesh_terms=Eye+Neoplasms#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thymocytes",
"description": "Quels traitements existent pour les anomalies des thymocytes ?\nLa transplantation de thymus est-elle une option ?\nLes traitements ciblent-ils spécifiquement les thymocytes ?\nLes thérapies biologiques sont-elles efficaces ?\nLes traitements sont-ils personnalisés selon le patient ?",
"url": "https://questionsmedicales.fr/mesh/D060168?mesh_terms=Eye+Neoplasms#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thymocytes",
"description": "Quelles complications peuvent survenir avec des thymocytes anormaux ?\nLes troubles auto-immuns sont-ils liés aux thymocytes ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D060168?mesh_terms=Eye+Neoplasms#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thymocytes",
"description": "Quels sont les facteurs de risque pour les anomalies des thymocytes ?\nL'âge influence-t-il le risque d'anomalies thymiques ?\nLes maladies génétiques augmentent-elles le risque ?\nLe mode de vie joue-t-il un rôle dans le risque ?\nLes expositions environnementales sont-elles un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D060168?mesh_terms=Eye+Neoplasms#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des thymocytes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des biopsies du thymus peuvent révéler des anomalies."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer les thymocytes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie par résonance magnétique et les analyses cytologiques sont courantes."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les thymocytes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des anomalies génétiques affectant le développement des thymocytes."
}
},
{
"@type": "Question",
"name": "Peut-on évaluer la fonction des thymocytes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests fonctionnels mesurant la réponse immunitaire peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont utilisés pour identifier les thymocytes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs CD4 et CD8 sont souvent utilisés pour caractériser les thymocytes."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec les thymocytes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections fréquentes et une immunodéficience peuvent signaler des problèmes."
}
},
{
"@type": "Question",
"name": "Les anomalies des thymocytes causent-elles des symptômes spécifiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des troubles auto-immuns et des lymphomes."
}
},
{
"@type": "Question",
"name": "Comment les thymocytes affectent-ils la santé globale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thymocytes dysfonctionnels peuvent compromettre la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les symptômes d'une maladie des thymocytes sont-ils visibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être subtils, souvent révélés par des infections récurrentes."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants peuvent présenter des symptômes plus marqués."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies liées aux thymocytes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain et des vaccinations peuvent aider à prévenir les infections."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives spécifiques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les expositions aux agents pathogènes et maintenir une bonne hygiène."
}
},
{
"@type": "Question",
"name": "Les dépistages réguliers sont-ils recommandés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, surtout pour les personnes à risque d'immunodéficience."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle la santé des thymocytes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la fonction immunitaire et des thymocytes."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les thymocytes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la fonction des thymocytes et l'immunité."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les anomalies des thymocytes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des immunosuppresseurs et des thérapies géniques."
}
},
{
"@type": "Question",
"name": "La transplantation de thymus est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être envisagée pour les patients avec des déficits immunitaires sévères."
}
},
{
"@type": "Question",
"name": "Les traitements ciblent-ils spécifiquement les thymocytes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains traitements visent à restaurer la fonction des thymocytes."
}
},
{
"@type": "Question",
"name": "Les thérapies biologiques sont-elles efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent moduler la réponse immunitaire et améliorer la fonction des thymocytes."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés selon le patient ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont souvent adaptés en fonction des besoins individuels."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des thymocytes anormaux ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections graves et des cancers comme les lymphomes peuvent se développer."
}
},
{
"@type": "Question",
"name": "Les troubles auto-immuns sont-ils liés aux thymocytes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des thymocytes dysfonctionnels peuvent contribuer à des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être traitées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent réduire la qualité de vie en augmentant la susceptibilité aux infections."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être fréquentes chez les personnes avec des anomalies thymiques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les anomalies des thymocytes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux et certaines infections virales augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'anomalies thymiques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies génétiques peuvent prédisposer à des anomalies des thymocytes."
}
},
{
"@type": "Question",
"name": "Le mode de vie joue-t-il un rôle dans le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie malsain peut augmenter le risque d'anomalies immunitaires."
}
},
{
"@type": "Question",
"name": "Les expositions environnementales sont-elles un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines expositions environnementales peuvent affecter la santé des thymocytes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 30/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.
Publications dans "Thymocytes" :
3 publications dans cette catégorie
Affiliations :
Institute of Biophysics and Biochemistry, National University of Uzbekistan, Tashkent, Uzbekistan.
Department of Biophysics, National University of Uzbekistan, Tashkent, Uzbekistan.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Special Key Laboratory of Gene Detection and Therapy of the Guizhou Province, Zunyi Medical University, Zunyi, China.
Department of Immunology, Zunyi Medical University, Zunyi, China.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Special Key Laboratory of Gene Detection and Therapy of the Guizhou Province, Zunyi Medical University, Zunyi, China, xulinzhouya@163.com.
Department of Immunology, Zunyi Medical University, Zunyi, China, xulinzhouya@163.com.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Genome Dynamics and Function Program, Genome Decoding Department, Severo Ochoa Molecular Biology Center (CBMSO), CSIC-Madrid Autonomous University, 28049 Madrid, Spain.
Institute of Health Research Jiménez Díaz Foundation, 28040 Madrid, Spain.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Genome Dynamics and Function Program, Genome Decoding Department, Severo Ochoa Molecular Biology Center (CBMSO), CSIC-Madrid Autonomous University, 28049 Madrid, Spain.
Institute of Health Research Jiménez Díaz Foundation, 28040 Madrid, Spain.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Congenital Cardiac Surgery, Hospital Universitario La Paz, 28046 Madrid, Spain.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Congenital Cardiac Surgery, Hospital Universitario La Paz, 28046 Madrid, Spain.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Genome Dynamics and Function Program, Genome Decoding Department, Severo Ochoa Molecular Biology Center (CBMSO), CSIC-Madrid Autonomous University, 28049 Madrid, Spain.
Institute of Health Research Jiménez Díaz Foundation, 28040 Madrid, Spain.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Genome Dynamics and Function Program, Genome Decoding Department, Severo Ochoa Molecular Biology Center (CBMSO), CSIC-Madrid Autonomous University, 28049 Madrid, Spain.
Institute of Health Research Jiménez Díaz Foundation, 28040 Madrid, Spain.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China; Zhejiang University-University of Edinburgh Institute, Zhejiang University, Haining, China; Department of Dermatology and Rheumatology in Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. Electronic address: lu_linrong@zju.edu.cn.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Department of Neurobiology and Behavior, Cornell University, Ithaca, NY, United States.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Thymocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Immunology, Beckman Research Institute of City of Hope, Duarte, CA 91010.
Irell & Manella Graduate School of Biological Sciences, City of Hope, Duarte, CA 91010.
Publications dans "Thymocytes" :
Cancer is a major cause of morbidity and mortality in solid organ transplantation. Nonmelanoma skin cancer (NMSC) such as basocellular (BCC) and spinocellular (SCC) carcinoma, are common in renal tran...
Adnexal neoplasms of the eyelid encompass a wide variety of benign and malignant tumors of sebaceous, follicular, and sweat gland origin. Due to the specialized structures of the eyelid, these neoplas...
OVOL1 is a gene that negatively regulates mesenchymal transformation, which allows epithelial cells to invade the stroma. On the other hand, it negatively regulates c-Myc, which has a positive effect ...
Cross-sectional cohort study of 36 samples including 6 squamous papillomas, 19 conjunctival intraepithelial neoplasms, 6 squamous carcinomas and 7 normal conjunctivae were evaluated using immunohistoc...
Percentages of 98 and 100 of the OSSN, and 57 and 71% of the normal conjunctivae expressed OVOL1 and c-Myc respectively, however, the mean H-score of OVOL1 and c-Myc was higher in the OSSN than in nor...
The expression of OVOL1 is a useful tool to differentiate between a squamous carcinoma of conjunctival intraepithelial neoplasms and papilloma. OVOL1 could play a role in the invasiveness of squamous ...
Malignant lymphomas of the eye and its adnexal structures account for approximately 5-15% of extranodal lymphomas. According to anatomic and biological criteria, two large groups of lymphomas in and a...
This article gives a summary of the classification and molecular pathology of various intraocular and periocular lymphomas as well as oncological systemic treatment with a focus on primary vitreoretin...
A selective literature search was carried out in PubMed on the topic of intraocular and periocular lymphomas and own experiences are presented....
The treatment of primary vitreoretinal lymphomas (PVRL) is an interdisciplinary challenge and despite the apparently localized disease, systemic treatment concepts are necessary to reduce the high ris...
A deep understanding of the biological and molecular principles of intraocular and periocular lymphomas forms a basic prerequisite for precise diagnostics and the use of targeted systemic treatment....
Eye plaque brachytherapy is currently an optimal therapy for intraocular cancers. Due to the lack of an effective and practical technique to measure the seed radioactivity distribution, current qualit...
In this study, a fast and low-cost radio-luminescent imaging and dose calculating system to verify the seed activity distribution for differential loading was developed....
A proof-of-concept system consisting of a thin scintillator sheet coupled to a camera/lens system was constructed. A seed-loaded plaque can be placed directly on the scintillator surface with the radi...
Data analyses showed high gamma (3%/0.3 mm, global, 20% threshold) passing rates for correct seed loadings and low passing rates with distinguished high gamma value area for incorrect loadings, indica...
Radio-luminescent QA can be used to facilitate and assure the implementation of intensity-modulated, customized plaque loading....
To evaluate the presenting complaints, surgical management, surgical outcomes, complications, and postoperative visual acuity following limbal dermoid excision....
Retrospective cohort study....
Medical records of patients with limbal dermoid presenting between January 2012 and December 2020 were retrieved to extract data regarding demographics, presenting profiles including the best-correcte...
Fifty-one eyes from 50 patients (27 males) were evaluated. The median age at the time of surgery was 11.5 years (interquartile range, IQR: 0.0-45.7). The median follow-up time was 5 years (IQR: 4-6). ...
Surgical management of limbal dermoids offers promising functional and anatomic outcomes. However, postoperative astigmatism may require further follow-up and management....
To report the demographic profile, clinical presentation, and management outcomes of ocular surface squamous neoplasia (OSSN) treated with primary topical chemotherapy in a limited resource secondary ...
Retrospective interventional study of 38 eyes of 37 patients with OSSN treated with topical 1% 5-Fluorouracil (5FU), over a period of two years....
The median age at presentation with OSSN was 44 years (mean, 46 years; range 13 to 74 years). Majority (76%) were males. The most common morphological variant was placoid OSSN (18, 47%). Limbus was th...
Primary chemotherapy with topical 1% 5FU is a safe and effective management modality for OSSN at limited resource settings in rural India....
To study the efficacy and side-effect profile of topical 5-Fluorouracil (5-FU) in the treatment of ocular surface squamous neoplasia (OSSN)....
Retrospective study of 101 eyes of 100 patients treated with 5-FU with one week on and 3 weeks off regimen....
Of the 100 patients (101 eyes), the mean age at diagnosis of OSSN was 49 (median, 52 years; range, 11-87 years). History of prior intervention was noted in 6 (6%) eyes. Tumor epicenter included bulbar...
Topical 5-FU is an effective non-invasive therapy for OSSN with a minimal side-effect profile....
To investigate the effect of using non-uniform loading and notched plaques on dose distribution for eye plaques. Using EGSnrc Monte Carlo (MC) simulations, we investigate eye plaque dose distributions...
The aim of this study was to relate common toxicity endpoints with dose to the macula, optic disc, and lens for uveal melanoma patients treated with Iodine-125 Collaborative Ocular Melanoma Study (COM...
A cohort of 52 patients treated at a single institution between 2005 and 2019 were retrospectively reviewed. Demographics, dosimetry, and clinical outcomes were recorded. Univariate, relative risk, an...
By the end of follow up (Median = 3.6 years, Range = 0.4 - 13.5 years), 65 % of eyes sustained radiation retinopathy, 40 % demonstrated moderate vision decline (>5 Snellen lines lost), and 56 % develo...
Dose-effect relationships exist for the macula and optic disc with respect to the loss of visual acuity and the development of retinopathy. To better preserve vision after treatment, further research ...